Source:http://linkedlifedata.com/resource/pubmed/id/20303928
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-5-3
|
pubmed:abstractText |
The interaction of 18-methoxycoronaridine (18-MC) with nicotinic acetylcholine receptors (AChRs) was compared with that for ibogaine and phencyclidine (PCP). The results established that 18-MC: (a) is more potent than ibogaine and PCP inhibiting (+/-)-epibatidine-induced AChR Ca(2+) influx. The potency of 18-MC is increased after longer pre-incubation periods, which is in agreement with the enhancement of [(3)H]cytisine binding to resting but activatable Torpedo AChRs, (b) binds to a single site in the Torpedo AChR with high affinity and inhibits [(3)H]TCP binding to desensitized AChRs in a steric fashion, suggesting the existence of overlapping sites. This is supported by our docking results indicating that 18-MC interacts with a domain located between the serine (position 6') and valine (position 13') rings, and (c) inhibits [(3)H]TCP, [(3)H]ibogaine, and [(3)H]18-MC binding to desensitized AChRs with higher affinity compared to resting AChRs. This can be partially attributed to a slower dissociation rate from the desensitized AChR compared to that from the resting AChR. The enthalpic contribution is more important than the entropic contribution when 18-MC binds to the desensitized AChR compared to that for the resting AChR, and vice versa. Ibogaine analogs inhibit the AChR by interacting with a luminal domain that is shared with PCP, and by inducing desensitization.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/18-methoxycoronaridine,
http://linkedlifedata.com/resource/pubmed/chemical/Cholinergic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Fish Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ibogaine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cholinergic
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0006-3002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1798
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1153-63
|
pubmed:meshHeading |
pubmed-meshheading:20303928-Animals,
pubmed-meshheading:20303928-Binding Sites,
pubmed-meshheading:20303928-Cholinergic Antagonists,
pubmed-meshheading:20303928-Electric Organ,
pubmed-meshheading:20303928-Fish Proteins,
pubmed-meshheading:20303928-Ibogaine,
pubmed-meshheading:20303928-Protein Binding,
pubmed-meshheading:20303928-Protein Structure, Tertiary,
pubmed-meshheading:20303928-Receptors, Cholinergic,
pubmed-meshheading:20303928-Torpedo
|
pubmed:year |
2010
|
pubmed:articleTitle |
Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational states.
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, College of Pharmacy, Midwestern University, Glendale, Arizona, USA. harias@midwestern.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural,
Research Support, N.I.H., Intramural
|